Clinical Trial Update: Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome

View source ↗

Summary

This document is an update on a clinical trial investigating the copper-to-zinc ratio in patients with end-stage renal disease, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Minia University | Conditions: ESRD (End Stage Renal Disease), Control Condition | Status: NOT_YET_RECRUITING